These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28058865)

  • 1. Impact of Pharmacist Intervention to Increase Compliance With Guideline-Directed Statin Therapy During an Acute Coronary Syndrome Hospitalization.
    Tunney RK; Johnson DC; Wang L; Cox ZL
    Ann Pharmacother; 2017 May; 51(5):394-400. PubMed ID: 28058865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
    Lee HY; Cooke CE; Robertson TA
    J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of pharmacist-initiated interventions in improving acute coronary syndrome secondary prevention pharmacotherapy prescribing upon discharge.
    Hassan Y; Kassab Y; Abd Aziz N; Akram H; Ismail O
    J Clin Pharm Ther; 2013 Apr; 38(2):97-100. PubMed ID: 23441979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of different intervention models on adherence to secondary prevention therapies in patients with acute coronary syndrome].
    Liu J; Wang W; Liu J; Wang Y; Qi Y; Sun JY; Zhao D
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Feb; 46(2):124-130. PubMed ID: 29495236
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines on the prescription of high-intensity statins in patients hospitalized for acute coronary syndrome or stroke.
    Valentino M; Al Danaf J; Panakos A; Ragupathi L; Duffy D; Whellan D
    Am Heart J; 2016 Nov; 181():130-136. PubMed ID: 27823684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a pharmacist-delivered discharge and follow-up intervention for patients with acute coronary syndromes in Qatar: a study protocol for a randomised controlled trial.
    Zidan A; Awaisu A; Kheir N; Mahfoud Z; Kaddoura R; AlYafei S; El Hajj MS
    BMJ Open; 2016 Nov; 6(11):e012141. PubMed ID: 27864247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin Utilization Patterns and Outcomes for Patients with Acute Coronary Syndrome During and Following Inpatient Admissions.
    Boklage SH; Malangone-Monaco E; Lopez-Gonzalez L; Ding Y; Henriques C; Elassal J
    Cardiovasc Drugs Ther; 2018 Jun; 32(3):273-280. PubMed ID: 29855748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential for coronary CT angiography to tailor medical therapy beyond preventive guideline-based recommendations: insights from the ROMICAT I trial.
    Pursnani A; Schlett CL; Mayrhofer T; Celeng C; Zakroysky P; Bamberg F; Nagurney JT; Truong QA; Hoffmann U
    J Cardiovasc Comput Tomogr; 2015; 9(3):193-201. PubMed ID: 25846248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention).
    Toso A; Leoncini M; Maioli M; Tropeano F; Di Vincenzo E; Villani S; Bellandi F
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1421-9. PubMed ID: 25523533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community Pharmacists Assisting in Total Cardiovascular Health (CPATCH): A Cluster-Randomized, Controlled Trial Testing a Focused Adherence Strategy Involving Community Pharmacies.
    Blackburn DF; Evans CD; Eurich DT; Mansell KD; Jorgenson DJ; Taylor JG; Semchuk WM; Shevchuk YM; Remillard AJ; Tran DA; Champagne AP
    Pharmacotherapy; 2016 Oct; 36(10):1055-1064. PubMed ID: 27581815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin initiation following coronary artery bypass grafting: outcome of a hospital discharge protocol.
    Khanderia U; Townsend KA; Eagle K; Prager R
    Chest; 2005 Feb; 127(2):455-63. PubMed ID: 15705982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community Pharmacy-Based Inducement Programs Associated With Better Medication Adherence: A Cohort Study.
    Simpson SH; Lin M; Eurich DT
    Ann Pharmacother; 2017 Aug; 51(8):630-639. PubMed ID: 28372491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of statins after hospitalization for coronary heart disease.
    Ye X; Gross CR; Schommer J; Cline R; Xuan J; St Peter WL
    J Manag Care Pharm; 2007 Jun; 13(5):385-96. PubMed ID: 17605510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Nonuse of a High-Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) Trial.
    Eisen A; Cannon CP; Braunwald E; Steen DL; Zhou J; Goodrich EL; Im K; Dalby AJ; Spinar J; Daga S; Lukas MA; O'Donoghue ML
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28077384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six-month adherence to Statin use and subsequent risk of major adverse cardiovascular events (MACE) in patients discharged with acute coronary syndromes.
    Xie G; Sun Y; Myint PK; Patel A; Yang X; Li M; Li X; Wu T; Li S; Gao R; Wu Y
    Lipids Health Dis; 2017 Aug; 16(1):155. PubMed ID: 28810873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary preventive medication use in a prevalent population-based cohort of acute coronary syndrome survivors.
    Gunnell AS; Hung J; Knuiman MW; Nedkoff L; Gillies M; Geelhoed E; Hobbs MS; Katzenellenbogen JM; Rankin JM; Ortiz M; Briffa TG; Sanfilippo FM
    Cardiovasc Ther; 2016 Dec; 34(6):423-430. PubMed ID: 27489053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bezafibrate treatment is associated with a reduced rate of re-hospitalization in smokers after acute coronary syndrome.
    Klempfner R; Goldenberg I; Fisman EZ; Amit U; Haitovich A; Matetzky S; Medvedofsky D; Shemesh J; Tenenbaum A
    Cardiol J; 2014; 21(4):364-9. PubMed ID: 24142677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of statin prescription in acute myocardial infarction: the French registry of Acute ST-elevation or non-ST-elevation Myocardial Infarction (FAST-MI).
    Ferrières J; Bataille V; Leclercq F; Geslin P; Ruidavets JB; Grollier G; Bernard P; Cambou JP; Simon T; Danchin N
    Atherosclerosis; 2009 Jun; 204(2):491-6. PubMed ID: 19004441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Statin Adherence Following an Acute Myocardial Infarction Among Older Adults: Patient Predictors and the Association With Follow-Up With Primary Care Providers and/or Cardiologists.
    Hickson RP; Robinson JG; Annis IE; Killeya-Jones LA; Korhonen MJ; Cole AL; Fang G
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29051213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant use of calcium channel blockers with dual antiplatelet therapy and re-hospitalization for acute coronary syndrome.
    Wang CY; Lin ZF; Lee CM; Tsai YW; Huang TY; Shen LJ; Hsiao FY
    Pharmacoepidemiol Drug Saf; 2017 Mar; 26(3):229-238. PubMed ID: 28067454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.